X-48478695-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000348411.3(FTSJ1):c.270G>T(p.Gly90=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,193,698 control chromosomes in the GnomAD database, including 2 homozygotes. There are 426 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0026 ( 1 hom., 83 hem., cov: 23)
Exomes 𝑓: 0.00093 ( 1 hom. 343 hem. )
Consequence
FTSJ1
ENST00000348411.3 synonymous
ENST00000348411.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.107
Genes affected
FTSJ1 (HGNC:13254): (FtsJ RNA 2'-O-methyltransferase 1) This gene encodes a member of the methyltransferase superfamily. The encoded protein localizes to the nucleolus, binds to S-adenosylmethionine, and may be involved in the processing and modification of ribosomal RNA. Mutations in this gene are associated with cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant X-48478695-G-T is Benign according to our data. Variant chrX-48478695-G-T is described in ClinVar as [Benign]. Clinvar id is 197290.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-48478695-G-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.107 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 83 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTSJ1 | NM_012280.4 | c.270G>T | p.Gly90= | synonymous_variant | 4/13 | ENST00000348411.3 | NP_036412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTSJ1 | ENST00000348411.3 | c.270G>T | p.Gly90= | synonymous_variant | 4/13 | 1 | NM_012280.4 | ENSP00000326948 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00262 AC: 295AN: 112399Hom.: 1 Cov.: 23 AF XY: 0.00246 AC XY: 85AN XY: 34561
GnomAD3 genomes
AF:
AC:
295
AN:
112399
Hom.:
Cov.:
23
AF XY:
AC XY:
85
AN XY:
34561
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00137 AC: 240AN: 174682Hom.: 0 AF XY: 0.00106 AC XY: 64AN XY: 60272
GnomAD3 exomes
AF:
AC:
240
AN:
174682
Hom.:
AF XY:
AC XY:
64
AN XY:
60272
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000927 AC: 1002AN: 1081248Hom.: 1 Cov.: 29 AF XY: 0.000986 AC XY: 343AN XY: 347790
GnomAD4 exome
AF:
AC:
1002
AN:
1081248
Hom.:
Cov.:
29
AF XY:
AC XY:
343
AN XY:
347790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00261 AC: 293AN: 112450Hom.: 1 Cov.: 23 AF XY: 0.00240 AC XY: 83AN XY: 34622
GnomAD4 genome
AF:
AC:
293
AN:
112450
Hom.:
Cov.:
23
AF XY:
AC XY:
83
AN XY:
34622
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 18, 2015 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at